Idexx Laboratories
IDXX
715 hedge funds and large institutions have $20.8B invested in Idexx Laboratories in 2019 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 207 increasing their positions, 284 reducing their positions, and 58 closing their positions.
66% more first-time investments, than exits
New positions opened: 96 | Existing positions closed: 58
50% more funds holding in top 10
Funds holding in top 10: 14 → 21 (+7)
22% more capital invested
Capital invested by funds: $17.1B → $20.8B (+$3.73B)
4% more funds holding
Funds holding: 685 → 715 (+30)
0.93% less ownership
Funds ownership: 88.88% → 87.95% (-0.93%)
27% less repeat investments, than reductions
Existing positions increased: 207 | Existing positions reduced: 284
67% less call options, than puts
Call options by funds: $25.8M | Put options by funds: $78.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$194M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$140M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$79.8M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$72.5M |
| 5 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$31.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$97.6M |
| 2 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$84.5M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$73M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$66.7M |
| 5 |
Renaissance Technologies
New York
|
-$48.3M |
IDXX Hedge Fund Activity: Q2 2019 in Review
715 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q2 2019, worth a combined $20.8B — up 22% from $17.1B a quarter earlier.
Buyers outnumbered sellers: 96 funds opened new IDXX positions and 58 closed out — a net gain of 38 holders — while 207 added to existing stakes and 284 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $194M. The largest seller was Goldman Sachs, cutting an estimated $97.6M.
- 715 institutional investors held Idexx Laboratories (IDXX) as of Q2 2019, up from 685 in Q1 2019.
- Funds reported $20.8B of Idexx Laboratories stock for Q2 2019, up 22% quarter-over-quarter.
- 96 funds opened new Idexx Laboratories positions in Q2 2019 and 58 closed out, a net change of +38 holders.
- The largest Idexx Laboratories buyer in Q2 2019 was T. Rowe Price Associates, an estimated $194M added.
- The largest Idexx Laboratories seller in Q2 2019 was Goldman Sachs, an estimated $97.6M sold.
Based on aggregated 13F filings for Q2 2019.